Cogent Biosciences Price Target Maintained With a $15.00/Share by Needham

Cogent Biosciences的價格目標保持在每股15.00美元，由Needham維持。

道瓊斯 · 12/10 21:37 · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.